Robere Posted - 1 month ago

$ATRX Strange as it maybe, I’m guessing that they either sent the files in to late which takes time, or their deadline time was up sending ATRX too the expert market, also maybe Just maybe they did file too late and otc didn’t have the time too see Their file and now wait in turn, However it can can take to September 30 to update So keep an eye out for this company, and let’s hope for the best for company to come threw Otherwise “Neutral “. And disappointed 😡

Robere Posted - 2 months ago

$ATRX It’s moved to the expert market Not very good, transfer agent is verified which is very strange, still watching 😡

Robere Posted - 4 months ago

$ATRX They are working on getting current.

Robere Posted - 5 months ago

$ATRX Needs a little fix😂

Robere Posted - 5 months ago

$ATRX That’s a little better, needs to stay over 01😂

Robere Posted - 5 months ago

$ATRX Watching for that annual report and quarterly

Braverabbit Posted - 5 months ago

$ATRX I have bought in! Novel Efficacious small molacule drug to treat Type 1 Diabetes/NASH. Also a Parkinson's drug.

Robere Posted - 6 months ago

$ATRX News is coming out soon!

Robere Posted - 01/31/24

$ATRX DTC stock increase, signs of a Something going on good.

Robere Posted - 01/30/24

$ATRX should see some news Shortly.👀

Last10K Posted - 8 months ago

$ATRX just filed with the SEC a Ending Agreement and a Financial Exhibit https://last10k.com/sec-filings/ATRX/0001493152-24-002907.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ATRX

cctranscripts Posted - 8 months ago

Termination of a Material Definitive https://www.conferencecalltranscripts.org/summary/?id=12877026 $ATRX

risenhoover Posted - 8 months ago

$ATRX / Adhera Therapeutics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2024 Adhera Therapeut https://fintel.io/doc/sec-adhera-therapeutics-inc-737207-8k-2024-january-18-19740-7583?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Last10K Posted - 8 months ago

$ATRX just filed with the SEC a Event for Officers https://last10k.com/sec-filings/ATRX/0001493152-24-002422.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ATRX

cctranscripts Posted - 8 months ago

Departure of Directors or Certain https://www.conferencecalltranscripts.org/summary/?id=12869266 $ATRX

risenhoover Posted - 8 months ago

$ATRX / Adhera Therapeutics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 Adhera Therapeuti https://fintel.io/doc/sec-adhera-therapeutics-inc-737207-8k-2024-january-16-19738-7123?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Robere Posted - 8 months ago

$ATRX Something is coming Have a great day everyone

Alarusso68 Posted - 8 months ago

$ATRX doesn't look like blue skies to me!

Trader008 Posted - 12/22/23

$ATRX Debt gone $640 k cash received in deal. Blue skies ahead. Updated s1 filing coming for uplist?

wedman Posted - 8 months ago

$RDGL and $ATRX - patience will pay on both.

Last10K Posted - 11/29/23

$ATRX just filed with the SEC a New Agreement and a Financial Exhibit https://last10k.com/sec-filings/ATRX/0001493152-23-043045.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ATRX

cctranscripts Posted - 11/29/23

Entry into a Material Definitive https://www.conferencecalltranscripts.org/summary/?id=12749029 $ATRX

Trader008 Posted - 11/21/23

$ATRX On August 11, 2023, the Company and Biodexa Pharmaceuticals PLC (“Biodexa”) entered into a non-binding summary of proposals for the assignment of the MLR-1023 Agreement to Biodexa. In connection with the summary of proposals, in August 2023, the Company received a $100,000 deposit which is reflected as a contract liability on the accompanying consolidated balance sheet as of September 30, 2023.

Last10K Posted - 9 months ago

$ATRX just filed a 10-Q Quarterly Report with 5 financial statements and 33 disclosures: https://last10k.com/sec-filings/atrx/0001493152-23-042138.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=atrx

EarningsInsider Posted - 9 months ago

Adhera Therapeutics, Inc. Files SEC Form 10-Q $ATRX https://www.marketbeat.com/stocks/OTCMKTS/ATRX/sec-filings/

cctranscripts Posted - 9 months ago

Marina Biotech, Inc. Just Filed Its Quarterly Report: NetLoss per Common ... https://www.conferencecalltranscripts.org/summary/?id=12724696 $ATRX

risenhoover Posted - 9 months ago

$ATRX / Adhera Therapeutics files form 10-Q https://fintel.io/doc/sec-adhera-therapeutics-inc-737207-10q-2023-november-20-19681-8625?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

cctranscripts Posted - 10 months ago

Notification of inability to timely file Form 10-Q or 10-QSB https://www.conferencecalltranscripts.org/summary/?id=12712322 $ATRX

risenhoover Posted - 10 months ago

$ATRX / Adhera Therapeutics files form NT 10-Q https://fintel.io/doc/sec-adhera-therapeutics-inc-737207-nt-10q-2023-november-15-19676-6840?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Trader008 Posted - 10 months ago

$ATRX Needs this deal with pubco IMO to get revenues on books for Nasdaq uplist. Good luck.